These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15262902)

  • 1. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
    Li JS; Berezny K; Kilaru R; Hazan L; Portman R; Hogg R; Jenkins RD; Kanani P; Cottrill CM; Mattoo TK; Zharkova L; Kozlova L; Weisman I; Deitchman D; Califf RM
    Hypertension; 2004 Sep; 44(3):289-93. PubMed ID: 15262902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences are seen in blood pressure response to fosinopril in hypertensive children.
    Menon S; Berezny KY; Kilaru R; Benjamin DK; Kay JD; Hazan L; Portman R; Hogg R; Deitchman D; Califf RM; Li JS
    Am Heart J; 2006 Aug; 152(2):394-9. PubMed ID: 16875928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    Vetter W
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):255S-261S. PubMed ID: 9366282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].
    Koch J; Greminger P; Simeon-Dubach D
    Praxis (Bern 1994); 1997 Nov; 86(45):1779-84. PubMed ID: 9446181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients.
    Hansson L; Forslund T; Höglund C; Istad H; Lederballe-Pedersen O; Kristinsson A; Segaard E; Svensson A; Aärynen M; Wahrenberg H; Wennersten G; Kjellström T
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):1-5. PubMed ID: 8797128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
    Wagstaff AJ; Davis R; McTavish D
    Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
    Zannad F; Kessler M; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P
    Kidney Int; 2006 Oct; 70(7):1318-24. PubMed ID: 16871247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the efficacy and safety of fosinopril in general practice in 19,435 hypertensive patients (FLIGHT Study)].
    Berdah J; Guest M; Salvador M
    Ann Cardiol Angeiol (Paris); 1998 Mar; 47(3):169-75. PubMed ID: 9772944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension.
    Pool JL; Cushman WC; Saini RK; Nwachuku CE; Battikha JP
    Am J Hypertens; 1997 Jan; 10(1):117-23. PubMed ID: 9008256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients.
    Zhang JL; Qin YW; Zheng X; Qiu JL; Zhao XX; Zou DJ
    Blood Press; 2010 Apr; 19(2):110-8. PubMed ID: 20053144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension.
    Wells T; Frame V; Soffer B; Shaw W; Zhang Z; Herrera P; Shahinfar S;
    J Clin Pharmacol; 2002 Aug; 42(8):870-80. PubMed ID: 12162469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.